LETROZOLE

Product NDC
24535-0801
11-digit product format
245350801
Labeler code
24535
Product ID
24535-0801_b826b788-446f-49c9-bca2-2a3e7bbc43eb
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
LETROZOLE
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Arab Pharmaceutical Manufacturing Co. PSC Ltd
Application
ANDA203796
Marketing category
ANDA
Marketing start
2016-06-03
Marketing end
0000-00-00
Substance
LETROZOLE
Active strength
3 mg/1
Pharmacologic classes
Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d50ad188-a2a9-1aec-5d6c-f8612e9e5867Product name420190528
4f1e9b6f-5fe1-47c9-ab31-3c39ee923083Product name220170713

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
24535-0801-1LETROZOLE30 in 1 BOTTLETABLET, FILM COATED303

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
24535-0801LETROZOLE TABLET, FILM COATED [ARAB PHARMACEUTICAL MANUFACTURING CO. PSC LTD]3Legacy NDC, 1 package rows20160629_968611f1-ef03-47a6-8dae-4834f77d23bd.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
200064letrozole 2.5 MG Oral TabletPSN968611f1-ef03-47a6-8dae-4834f77d23bd3
200064letrozole 2.5 MG Oral TabletSCD968611f1-ef03-47a6-8dae-4834f77d23bd3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
24535-0801-12453508010130 in 1 BOTTLEHistorical